MHC mismatch inhibits neurogenesis and neuron maturation in stem cell allografts.

The role of histocompatibility and immune recognition in stem cell transplant therapy has been controversial, with many reports arguing that undifferentiated stem cells are protected from immune recognition due to the absence of major histocompatibility complex (MHC) markers. This argument is even more persuasive in transplantation into the central nervous system (CNS) where the graft rejection response is minimal. In this study, we evaluate graft survival and neuron production in perfectly matched vs. strongly mismatched neural stem cells transplanted into the hippocampus in mice. Although allogeneic cells survive, we observe that MHC-mismatch decreases surviving cell numbers and strongly inhibits the differentiation and retention of graft-derived as well as endogenously produced new neurons. Immune suppression with cyclosporine-A did not improve outcome but non-steroidal anti-inflammatory drugs, indomethacin or rosiglitazone, were able to restore allogeneic neuron production, integration and retention to the level of syngeneic grafts. These results suggest an important but unsuspected role for innate, rather than adaptive, immunity in the survival and function of MHC-mismatched cellular grafts in the CNS.

Citation

Zhiguo Chen, Lori K Phillips, Elizabeth Gould, Jay Campisi, Star W Lee, Brandi K Ormerod, Monika Zwierzchoniewska, Olivia M Martinez, Theo D Palmer. MHC mismatch inhibits neurogenesis and neuron maturation in stem cell allografts. PloS one. 2011;6(3):e14787

Mesh Tags

Substances

PMID: 21479168

search → result